JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merriman, C. R.
Right arrow Articles by Kampschmidt, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merriman, C. R.
Right arrow Articles by Kampschmidt, R. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
*IRON
Journal of Pharmacology And Experimental Therapeutics, Vol. 188, Issue 3, 516-519, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics


PROSTAGLANDIN E1, ASPIRIN AND THE ACTION OF LEUKOCYTIC ENDOGENOUS MEDIATOR

Charles R. Merriman 1, Herbert F. Upchurch 1, and Ralph F. Kampschmidt 1

1 Biomedical Division, The Samuel Roberts Noble Foundation, Inc., Ardmore, Oklahoma

Leukocytic endogenous mediator (LEM) induces numerous changes typical of those seen during the acute phase of inflammation. The possibility that LEM was acting through prostaglandin E1 (PGE1) was investigated. PGE1 failed to mimic the effects of LEM when injected intracisternally or intravenously. Injection of PGE1 intracisternally increased temperature in rats whereas injections of LEM produced hypothermia. Aspirin, an inhibitor of prostaglandin synthesis, did not block LEM induced release of neutrophils from the bone marrow or the lowering of plasma iron levels. The combination of these two findings plus the variety of routes used to administer both PGE1 and aspirin make it unlikely that PGE1 is involved in either lowering of plasma iron or the release of neutrophils from the bone marrow during the acute phase of inflammation.

Submitted on May 29, 1973
Accepted on November 14, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.